This inventor holds 1 USPTO granted patent. Top assignee: Arexis Ab. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: L G Joakim Galli: Innovator in Diabetes Research
Introduction
L G Joakim Galli is a notable inventor based in Täby, Sweden. He has made significant contributions to the field of diabetes research, particularly in the development of animal models that mimic non-insulin dependent diabetes mellitus. His work has implications for understanding and treating type II diabetes.
Latest Patents
Galli holds a patent for "Congenic animal models of non-insulin dependent diabetes mellitus." This patent describes congenic animals and animal populations that exhibit type II diabetes-associated phenotypes. Additionally, it details insulin degradation polypeptides that have amino acid substitutions linked to these phenotypes. This innovative approach provides valuable tools for research in diabetes.
Career Highlights
Galli is associated with Arexis AB, a company focused on advancing medical research and therapies. His work at Arexis AB has allowed him to contribute to groundbreaking research in diabetes and related fields. His expertise and dedication have positioned him as a key figure in this area of study.
Collaborations
Galli collaborates with L Holger Luthman, who is also involved in diabetes research. Their partnership enhances the research efforts at Arexis AB and contributes to the advancement of knowledge in the field.
Conclusion
L G Joakim Galli's innovative work in diabetes research, particularly through his patent on congenic animal models, showcases his commitment to advancing medical science. His contributions are vital for understanding type II diabetes and developing potential treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile